---
title: "Management: Stages Iâ€“II"
date: "2023-06-13"
enableToc: false
---

> [!info] 
> 
> ðŸŒ±ä¾†è‡ª: [[Management of follicular lymphoma]]

# Management: Stages Iâ€“II
ISRT alone results in 10-y RFS of ~40% w/ Stage I pts faring better than Stage II (JCO 1996;14:1282). The current recommended dose is 2400 cGy
Observation in selected cases where ISRT may result in significant morbidity w/ systemic being employed when indicated by NCCN/GELF criteria, as for Stages IIIâ€“IV

